会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 51. 发明申请
    • IMPLANTABLE MEDICAL DEVICE LEAD CONNECTION ASSEMBLY
    • 可植入医疗设备引线连接组件
    • US20100114210A1
    • 2010-05-06
    • US12363375
    • 2009-01-30
    • William T. DonofrioJohn E. BurnesPaul G. Krause
    • William T. DonofrioJohn E. BurnesPaul G. Krause
    • A61N1/375A61N1/39
    • A61N1/3752H01R13/5224H01R24/58H01R2107/00H01R2201/12Y10S439/909
    • A lead connection assembly of an implantable medical device (IMD) may include at least two different types of electrical connectors. In some examples, the lead connection assembly may include first and second electrical connectors that have at least one of a different electrical contact arrangement, a different lead connection receptacle geometry or a different size than the first electrical connector. The first electrical connector may be electrically connected to a first therapy module that generates cardiac rhythm therapy that is delivered to a heart of a patient, and the second electrical connector may be electrically connected to a second therapy module that generates electrical stimulation that is delivered to a tissue site within the patient. The second electrical connector may be configured to be incompatible with a lead that delivers the cardiac rhythm therapy to the patient.
    • 可植入医疗装置(IMD)的引线连接组件可以包括至少两种不同类型的电连接器。 在一些示例中,引线连接组件可以包括具有与第一电连接器不同的电接触布置,不同引线连接插座几何形状或不同尺寸中的至少一个的第一和第二电连接器。 第一电连接器可以电连接到第一治疗模块,该第一治疗模块产生被递送到患者的心脏的心律疗法,并且第二电连接器可以电连接到产生电刺激的第二治疗模块,该电刺激被递送到 患者内的组织部位。 第二电连接器可以被配置为与将心律治疗递送给患者的引线不相容。
    • 57. 发明授权
    • Algorithm for the automatic determination of optimal pacing intervals
    • 自动确定最佳起搏间隔的算法
    • US07711423B2
    • 2010-05-04
    • US11135921
    • 2005-05-24
    • John E. BurnesDavid A. IgelJohn C. RueterYong K. ChoLuc R. MongeonHarold E. StoneJodi Zilinski
    • John E. BurnesDavid A. IgelJohn C. RueterYong K. ChoLuc R. MongeonHarold E. StoneJodi Zilinski
    • A61N1/362
    • A61N1/36521
    • Impedance, e.g. sub-threshold impedance, is measured across the heart at selected cardiac cycle times as a measure of chamber expansion or contraction. One embodiment measures impedance over a long AV interval to obtain the minimum impedance, indicative of maximum ventricular expansion, in order to set the AV interval. Another embodiment measures impedance change over a cycle and varies the AV pace interval in a binary search to converge on the AV interval causing maximum impedance change indicative of maximum ventricular output. Another method varies the right ventricle to left ventricle (VV) interval to converge on an impedance maximum indicative of minimum cardiac volume at end systole. Another embodiment varies the VV interval to maximize impedance change. Other methods vary the AA interval to maximize impedance change over the entire cardiac cycle or during the atrial cycle.
    • 阻抗,例如 亚阈值阻抗是在选定心脏周期时间内心脏测量的,作为腔室扩张或收缩的量度。 为了设定AV间隔,一个实施例测量长AV间隔上的阻抗以获得指示最大心室扩张的最小阻抗。 另一个实施例测量一个周期的阻抗变化,并且改变二进制搜索中的AV步速间隔以收敛于AV间隔,从而引起指示最大心室输出的最大阻抗变化。 另一种方法将右心室改变为左心室(VV)间隔,以收敛于指示最终心脏收缩最小心脏容积的阻抗最大值。 另一实施例改变VV间隔以最大化阻抗变化。 其他方法改变AA间隔以最大化整个心动周期或心房周期期间的阻抗变化。